Technical Articles
IGF bioavailability
Why IGFBP-4 Mostly Brakes: Structure, Affinity and the PAPP-A Cleavage Step
IGFBP-4 holds IGFs in an inactive complex until PAPP-A proteolysis releases them. This article maps the brake-to-release sequence and its structural basis.
View details
- Signaling Pathway
- IGFBP-4
- PAPP-A
- IGF release
- proteolysis
- pregnancy
- IGF bioavailability
- UA040534
Why IGFBP-5 Sequesters Ligand While Binding Matrix: One Chain with Two Jobs
IGFBP-5 carries an IGF-binding pocket and a heparin/matrix-binding face on one chain. This article maps the dual-track behavior and what each track changes.
View details
- Signaling Pathway
- IGFBP-5
- IGF binding protein
- matrix binding
- heparin
- IGF bioavailability
- UA040394
- 1







